The following services are available at this hospital trust (updated 2021). Men diagnosed at this trust may be able to access additional services from other trusts within the specialist multidisciplinary team:

• Diagnostic Facilities:
• Multiparametric MRI
• Transperineal biopsy under local anaesthetic
• Transperineal biopsy under general anaesthetic
• Transrectal ultrasound (TRUS) biopsy
• Choline PET
• PSMA (prostate-specific membrane antigen) PET scan
• Isotope bone scan

• Treatment Facilities:
• Radical prostatectomy
• Robot assisted laparoscopic prostatectomy
• External beam radiotherapy (EBRT)
• Chemotherapy
• Clinical trials unit

• Support Service Facilities:
• Advanced PCa CNS
• Urology CNS
• Sexual function services
• Specialist continence services

For these results, data for England were provided for 1st April 2019 to 31st March 2020 from the Rapid Cancer Registration Dataset (RCRD), which is sourced mainly from the Cancer Services and Outcomes Dataset (COSD) containing proxy tumour registrations, as the standard Cancer Registration data were unavailable. More details can be found here. Please note: the data quality results were amended in May 2022.

	Diagnosing Trust	Specialist MDT
No. of Cancer Registry records	673	673
Performance Status recorded	84%	84%
TNM completed	65%	65%
Stage variable assigned	74%	74%

	Specialist MDT	National
No. of men with disease status determined	497	34801
Percentage of men diagnosed with metastatic disease	13%	13%

These indicators could not be reported this year for England as we were unable to assign a patient to a particular risk group due to the unavailability of information on PSA and Gleason score in the Rapid Cancer Registration Dataset

	Treatment Centre
No. of men who received radical prostatectomy (2019-2020)	137
Adjusted percentage of men who had an emergency readmission within 90 days of radical prostatectomy (%)	28%
No. of men who received radical prostatectomy (2018)	147
Adjusted percentage of men experiencing at least one GU complication (%)	13%